Today I sorted through notebooks from my practice to organize the material and as I did so I noticed a few things I thought might be worth sharing with you. By the way, what struck me was the fact that much of what I’ve used in trial over the years was originally someone else’s thought or idea. A whole lot of “new” tactics and ideas are really old ones with new dressing on them. But, here you are and in no…
Ashley Parker in the October 5th edition of the New York Times wrote an article entitled Digital Ads Sell Candidates and Causes in 15 second Bursts.” She writes: “Fifteen seconds is not a lot of time in this world of political advertising to make a compelling statement or share a riveting candidate story. But in the attention – deficit era of politics, with voters consuming more and more news on mobile devices, campaigns and the groups supporting them are devoting significant resources…
The Huffington Post has been publishing Steven Brill’s writing about Johnson & Johnson’s Risperdal product and the litigation involved. If you haven’t read it you should. It’s very well written and informative. See it at: http://highline.huffingtonpost.com/miracleindustry/americas-most-admired-lawbreaker/chapter-1.html The product resulted in major litigation. For example, the nation’s largest nursing home pharmacy, Omnicare Inc. of Covington, Kentucky paid a $98 million penalty for accepting kickbacks from Johnson & Johnson in exchange for agreeing to recommend that physicians prescribe Risperdal to nursing home patients….